Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/14/2017 07/17/2017 07/18/2017 07/19/2017 07/20/2017 Date
127.625(c) 126.5(c) 128(c) 128.5(c) 124(c) Last
0 0 109 0 272 Volume
+1.39% -0.88% +1.19% +0.39% -3.50% Change
More quotes
Financials ($)
Sales 2017 1,85 M
EBIT 2017 -100 M
Net income 2017 -66,8 M
Debt 2017 4,43 M
Yield 2017 -
Sales 2018 1,80 M
EBIT 2018 -112 M
Net income 2018 -77,3 M
Finance 2018 35,6 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 210x
EV / Sales2018 193x
Capitalization 383 M
More Financials
Company
PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune.It operates through the following segments: Growth Stage Businesses; Project Phase Businesses; and... 
More about the company
Surperformance© ratings of Puretech Health PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on PURETECH HEALTH PLC
07/13 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Visit in the Pivotal Gelesis100..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Out in the Pivotal Gelesis100 W..
06/28 PURETECH HEALTH : Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chai..
06/28 PURETECH HEALTH : Former Cubist CEO, DreamWorks Interactive CEO, and Google Chie..
06/01 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
05/30 PURETECH HEALTH : Vedanta Biosciences Granted U.S. Patent Broadly Covering Metho..
05/30 VEDANTA BIOSCIENCES : Granted U.S. Patent Broadly Covering Methods of Treatment ..
05/25 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
05/25 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
More news
Sector news : Biotechnology & Medical Research - NEC
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/12 FDA panel backs Novartis' pioneering new cancer gene therapy
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
07/13PureTech Health Presents Data Supporting Treatment Approach for Interstitial .. 
07/12PureTech Health : Gelesis Announces Last Patient Visit in the Pivotal Gelesis.. 
07/12Puretech Health PLC's buy rating reiterated at Liberum Capital. GBX 248 PT.  
06/09Puretech Health PLC's buy rating reiterated at Jefferies Group LLC. GBX 255 P.. 
05/25PureTech Health to Present at Jefferies 2017 Global Healthcare Conference  
More tweets
Qtime:10
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,13 $
Spread / Average Target 94%
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Michael F. MacLean Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC5.20%383
INCYTE CORPORATION33.43%27 397
QUINTILES IMS HOLDINGS INC19.61%19 489
LONZA GROUP33.19%16 967
CELLTRION, INC.--.--%12 547
ALKERMES PLC3.51%8 813